Skip to main content
Nikolaos Trikalinos, MD, Oncology, Saint Louis, MO

Nikolaos Trikalinos MD


Physician

Join to View Full Profile
  • 4921 Parkview Pl# DvSaint Louis, MO 63110

  • Phone+1 800-647-2098

  • Fax+1 314-362-3192

Dr. Trikalinos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • John Hopkins University
    John Hopkins UniversityMaster's, Regulatory Science, 2016
  • University of Maryland
    University of MarylandFellowship, Hematology and Medical Oncology, 2011 - 2014
  • MetroWest Medical Center
    MetroWest Medical CenterResidency, Internal Medicine, 2007 - 2011
  • University of Ioannina Faculty of Medicine
    University of Ioannina Faculty of MedicineClass of 2005

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2020 - 2026
  • MO State Medical License
    MO State Medical License 2017 - 2026
  • MD State Medical License
    MD State Medical License 2014 - 2017
  • MA State Medical License
    MA State Medical License 2010 - 2013
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Excellence in Research Award US Oncology Network, 2015
  • Outstanding Performance Award Metrowest Medical Center, 2011
  • Compliance Award, Outstanding Documentation University of Maryland, 2011
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • FOLFIRINOX for the Treatment of Advanced Gastroesophageal Cancers  
    Haeseong Park, Andrea Wang-Gillam, Caron Rigden, Katrina S Pedersen, Nikolaos A Trikalinos, JAMA Oncology
  • Socioeconomic status and survival in glioblastoma  
    Trikalinos NA, Goloubeva O, Mehta MP, Kwok Y, Sausville E, Int J Clin Exp Med, 1/1/2016
  • International ranking systems for universities and institutions: a critical appraisal  
    Ioannidis JP, et al, BMC Med, 1/25/2007

Abstracts/Posters

  • Preoperative monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio are associated with overall survival after resection of pancreatic neuroendocrine tumors.
    Roheena Z. Panni, Bradley Krasnick, Jesse Davidson, Alexandra G. Lopez-Aguiar, Eleftherios Makris, George Poultsides, Zaheer Kanji, Flavio Rocha, Alexander V. Fisher, ..., Gastrointestinal Cancers Symposium, 1/1/2018
  • A phase II trial of first-line FOLFIRINOX for patients with advanced gastroesophageal adenocarcinoma.
    Haeseong Park, Andrea Wang-Gillam, Rama Suresh, Caron E. Rigden, Manik A. Amin, Benjamin R. Tan Jr., Katrina Pedersen, Kian-Huat Lim, Nikolaos Trikalinos, Katherine Na..., Gastrointestinal Cancers Symposium, 1/1/2018
  • Grade switch and survival in a cohort of 95 resected pancreatic neuroendocrine neoplasms (PanNEN).
    Nikolaos A Trikalinos, Chet Hammill, Gregory Williams, Jingxia Liu, William Hawkins and Deyali Chatterjee, North American Neuroendocrine Tumors Society Symposium, 1/1/2018
  • Join now to see all

Lectures

  • Colorectal cancer. 
    1/12/2018

Other

  • Assessing the Accuracy of Google Translate To Allow Data Extraction From Trials. 
    Balk, et al, AHRQ Methods Research Report

Authored Content

  • FOLFIRINOX for the Treatment of Advanced Gastroesophageal CancersMay 2020

Press Mentions

  • Siteman Cancer Center to Open North St. Louis County Location July 1
    Siteman Cancer Center to Open North St. Louis County Location July 1June 30th, 2017

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: